Overview

Drug Interaction Study of ASC42 With Atorvastatin

Status:
Not yet recruiting
Trial end date:
2022-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether ASC42 alters the pharmacokinetics of atorvastatin in healthy subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Gannex Pharma Co., Ltd.
Treatments:
Atorvastatin